AeroLeads people directory · profile

Pedro Borralho Email & Phone Number

Radioligand Therapies Lead @Novartis at Novartis
Location: Lisboa, Lisbon, Portugal 15 work roles 7 schools
1 work email found @novartis.com LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email p****@novartis.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Radioligand Therapies Lead @Novartis
Location
Lisboa, Lisbon, Portugal
Company size

Who is Pedro Borralho? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Pedro Borralho is listed as Radioligand Therapies Lead @Novartis at Novartis, a with 100036 employees, based in Lisboa, Lisbon, Portugal. AeroLeads shows a work email signal at novartis.com and a matched LinkedIn profile for Pedro Borralho.

Pedro Borralho previously worked as Western European Countries (WEC) Lead - Pluvicto at Novartis and Radioligand Therapies Lead at Novartis Portugal. Pedro Borralho holds Ph.D, Pharmacy-Biochemistry, Laude And Honors from Faculty Of Pharmacy Of The University Of Lisbon.

Company email context

Email format at Novartis

This section adds company-level context without repeating Pedro Borralho's masked contact details.

{first}.{last}@novartis.com
89% confidence

AeroLeads found 1 current-domain work email signal for Pedro Borralho. Compare company email patterns before reaching out.

Profile bio

About Pedro Borralho

Widely experienced Pharma professional with 8 years of experience in Big Pharma, both in commercial (3 Years) and Medical Affairs roles (5 years), with strong leadership track across different Therapeutic Areas & Brands, and cross-functional high performing teams, complemented with 15 years of experience in pre- and post-graduate teaching, lecturing and mentoring, and 12 years of career track in basic and translational research in cancer. Strong track in Cross-functional Team leadership, in multiple therapeutic areas and brands, with commercial responsibility for coordinating Key Brand Launches in oncology (Pluvicto, Locametz) and relevant medical affairs contributions to support other launches (Piqray, Zykadia, Tafinlar-Mekinist, Ribociclib). Commercial experience as Radioligand Therapies Lead (responsibility across all Radioligand Therapy and imaging Portfolio; 4 brands in 2 TAs; (Pluvicto) Prostate cancer and (Lutathera) NET), and Squad Lead in Precision Oncology (responsibility across all Solid tumors and Hematology), complemented by Disease Area Team Leadership (NET & Lung Cancer) and medical Affairs experience as Precision Oncology Advisor and Medical Scientific Liaison across multiple solid tumor TAs (Lung cancer, melanoma, Breast Cancer, NET, Sarcoma).Biotechnology Engineering Degree (pre-bologna), PhD in Pharmacy (summa cum laude), with 12 year track in basic and translational research in colon cancer, liver diseases and neurosciences, and >15 year track in teaching and lecturing at pre- and post-graduated level.Author and co-author of 45 articles published in international peer-reviewed journals, 3 invited book chapters (>3500 citations, h-index=33). Supervisor of 3 PhD thesis, Supervisor & mentor of >30 PhD/MsC/undergraduates; Guest Associate Editor in Frontiers in Molecular Biosciences 2021. Peer reviewer for 20 international peer-reviewed journals (since 2007). Participated in 20 national and international research grants. Member of over 40 Evaluation committees (PhD/MsC/other post-graduate examinations).(All contributions, opinions and activity done by Pedro within Linkedin are individual opinions and contributions, and do not in any way reflect the official policy or position of any company Pedro is employee of.)

Listed skills include Cancer Research, Cancer, Biochemistry, Molecular Biology, and 13 others.

Current workplace

Pedro Borralho's current company

Company context helps verify the profile and gives searchers a useful next step.

Novartis
Novartis
Radioligand Therapies Lead @Novartis
basel, basel-city, switzerland
Website
Employees
100036
AeroLeads page
15 roles · 21 years

Pedro Borralho work experience

A career timeline built from the work history available for this profile.

Western European Countries (Wec) Lead - Pluvicto

Current

Coordination of cross-country Team comprising all WEC Country RLT Commercial Heads & country RLT Medical Leads, liaising with WEC, International Markets, Global and Region Europe.WEC Cluster: Switzerland, Austria, Portugal, Netherlands, Belgium& Luxemburg

Jan 2024 - Present

Radioligand Therapies Lead

Current

Portugal

Cross-functional Team Leadership Leading & coordinating Pluvicto & Locametz Launch and business setupBrand and commercial Lead of RLT + RLI Brands (Pluvicto, Lutathera, Somakit, Locametz)

Jan 2023 - Present

Squad Lead -Diagnostics & Precision Oncology

Portugal

Squad Lead Diagnostics Acceleration & Capabilities

Oct 2021 - Mar 2023

Precision Oncology Scientific Advisor

Lisbon Area, Portugal

Solid Tumors & Hematology

Jan 2019 - Sep 2021

Disease Area Team Lead - Lung Cancer & Neuroendocrine Tumors

Lisbon Area, Portugal

Lung Cancer & Neuroendocrine Tumors

Apr 2018 - Dec 2018

Medical Scientific Liaison

Porto Salvo, Portugal

Oncology Medical Scientific Liaison – Solid Tumors• Breast Cancer• Lung Cancer• Neuroendocrine Tumors• Soft Tissue Sarcoma

Nov 2015 - Dec 2018

Precision Oncology Scientific Advisor

Jul 2021 - Sep 2021

Lecturer

Lisbon, Portugal

Lecturer at Faculty of Pharmacy, University of Lisbon; Department of Biochemistry and Human Biology𝟭. 𝗣𝗼𝘀𝘁-𝗴𝗿𝗮𝗱𝘂𝗮𝘁𝗲 𝗰𝘂𝗿𝗿𝗶𝗰𝘂𝗹𝗮𝗿 𝘂𝗻𝗶𝘁𝘀:1.1 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗠𝗮𝘀𝘁𝗲𝗿 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀:2007 - 2014 (7 years) Biochemistry of Cell Death2012 - 2015 (3 years) Biochemistry II𝟭.𝟮 - 𝗠𝗮𝘀𝘁𝗲𝗿/𝗣𝗵𝗗 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 𝗶𝗻 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀: 2015: Organizing comittee- FCT PhD Programme in Medicines and Pharmaceutical Innovation (i3DU), training course on Biomarkers and Assay Development + Lecture on "RNA biomarkers in cancer: from diagnosis to prognosis and therapy response"2017-2019: (3 years) Invited Lecturer & Workshop organizer on "Personalized Medicine in Cancer"- FCT PhD Programme in Medicines and Pharmaceutical Innovation (i3DU), training course on Biomarkers and Assay Development: 2021 Oncobiology2010-2020 (11 years) Oncobiology and Developmental Biology (Regent 2014-2015) 2010-2015 (6 years) Cell Signaling 2010-2015 Project I 2010-2015 Project II2014-2019 (6 years) Pharmacogenomics 2. Post-graduate Specialization Courses2005/2007/2009 “Biology of Cell Death I: Mechanisms of Apoptosis”2006 “Biology of Cell Death II: Mechanisms of Apoptosis”2009 “Research Workshop: Monitoring Cell Death”

2006 - Mar 2021

Post-Doctoral Researcher

iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences and Instituto Português de Oncologia de Francisco Gentil E.P.E. (IPOLFG), Lisbon

Jan 2010 - Dec 2011

Invited Assistant Professor

Lisboa E Região, Portugal

Regency of post graduate curricular units:2009-2010 - "Oncogenesis", Post-Graduation in Clinical and Laboratorial Genetics2011-20122013-2014 - "Biotechnology and Cancer", Masters in Biotechnology Engineering.

Feb 2010 - Jun 2014

Research Specialist - Department Of Medicine, Division Of Gastroenterology, Hepatology And Nutrition

Minneapolis

Feb 2006 - Jan 2010
Team & coworkers

Colleagues at Novartis

Other employees you can reach at novartis.com. View company contacts for 100036 employees →

7 education records

Pedro Borralho education

Post Graduated Course On Laboratory Animal Science - X Curso De Experimentação Animal (100H), Felasa Category C Accreditation

Faculty Of Veterinary Medicine, Technical University Of Lisbon, Lisbon, Portugal

Post Graduated Course On Non-Clinical Safety Sciences And Their Regulatory Aspects (Dia#10562) (45H)

Drug Information Agency (Dia) - Faculty Of Pharmacy, University Of Lisbon (Ffulisboa)

Preceptorship On Neuroendocrine Tumors, Neuroendocrine Tumors

Activities and Societies: NNTG-Nordic Neuroendocrine Tumor Group

FAQ

Frequently asked questions about Pedro Borralho

Quick answers generated from the profile data available on this page.

What company does Pedro Borralho work for?

Pedro Borralho works for Novartis.

What is Pedro Borralho's role at Novartis?

Pedro Borralho is listed as Radioligand Therapies Lead @Novartis at Novartis.

What is Pedro Borralho's email address?

AeroLeads has found 1 work email signal at @novartis.com for Pedro Borralho at Novartis.

Where is Pedro Borralho based?

Pedro Borralho is based in Lisboa, Lisbon, Portugal while working with Novartis.

What companies has Pedro Borralho worked for?

Pedro Borralho has worked for Novartis, Novartis Portugal, Novartis Oncology, Novartis Belux, and Faculty Of Pharmacy Of The University Of Lisbon.

Who are Pedro Borralho's colleagues at Novartis?

Pedro Borralho's colleagues at Novartis include Hasnain Sherwani, Alette Ramos Hunt, Phd, Stefania Montaño, Robert Thornton, and Bryan Culverhouse Crews, Mba.

How can I contact Pedro Borralho?

You can use AeroLeads to view verified contact signals for Pedro Borralho at Novartis, including work email, phone, and LinkedIn data when available.

What schools did Pedro Borralho attend?

Pedro Borralho holds Ph.D, Pharmacy-Biochemistry, Laude And Honors from Faculty Of Pharmacy Of The University Of Lisbon.

What skills is Pedro Borralho known for?

Pedro Borralho is listed with skills including Cancer Research, Cancer, Biochemistry, Molecular Biology, Biotechnology, Cell, Lifesciences, and Science.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Pedro Borralho you were looking for.

View similar profiles